Syros Pharmaceuticals Inc.
LSE
Closed
Aug 11, 2026
Day's Range
0.000001052 wk Range
0.0000010Key Statistics
Symbol
0LC7
Name
Syros Pharmaceuticals Inc.
Currency
USD
Exchange
LSE
High
0.000001
Low
0.000001
Open
‪0.0000010‬
Last
‪0.0000010‬
Market Cap
0
Volume
30
Average Volume
1.27K
Dividend Yield
‪0.00%‬
Change
-0.000099
Percent Change
-99.00
Timestamp
2026-08-11
Close
0.000001
Today Range Start
‪0.0000010‬
Today Range End
‪0.0000010‬
52 Week Range Start
‪0.0000010‬
52 Week Range End
‪0.00500‬
Type
Stocks
Country
United States
Historical Data - 0LC7 - Syros Pharmaceuticals Inc.
Historical Data
Profile - 0LC7 - Syros Pharmaceuticals Inc.
Profile
Mic Code
XLON
Sector
Healthcare
Industry
Biotechnology
Employees
68
Syros Pharmaceuticals Inc. is a biopharmaceutical company that focuses on discovering and developing medicines to control the expression of genes with the goal of treating diseases. The primary function of Syros Pharmaceuticals is to leverage its proprietary platform to identify and target gene regulatory regions to create therapeutics for cancer and other challenging diseases. Key features of the company include its emphasis on precision medicine, using gene regulatory analysis to pioneer drug discovery and development. Syros Pharmaceuticals plays a crucial role in the biotechnology sector by expanding treatment options for conditions that are currently underserved by existing therapies. Its innovative approach is redefining how genetic medicine can be applied to modern healthcare problems. Based in Cambridge, Massachusetts, Syros aims to produce novel therapeutics that address the underlying causes of disease, offering hope for patients through its groundbreaking scientific research and development.
Profile Details
Type
Common Stock
Address
35 CambridgePark Drive
City
Cambridge
State
MA
Zip
02140
Country
United States
Phone
617 744 1340
